drugset / Trial / NCT02632903
Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study
NaSingle-groupOpen-labelTreatment
Summary
This study explores the effect of zoledronic acid on incident vertebral fractures and osteonecrotic lesions in children recently diagnosed with acute lymphoblastic leukemia.
Timeline
- Start
- 2016-10
- Primary completion
- 2018-03
- Completion
- 2018-08-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zoledronic acid | Other / unclassified | 0.025 mg/kg | — |